ABSTRACT
Coronaviruses are infectious respiratory tract illnesses, but they can also affect the digestive tract and infect both humans and animals. The new coronavirus results in complicated health problems all over the world. The most urgent concern of all researchers around the world has been the treatment of the virus. The following study aimed to use quantitative ethnobotany to help scientist in addressing the deadly virus. Expert sampling method was adopted with the aid of an in-depth interview guide. Thirty-nine respondents were interviewed. Eighty-one medicinal plant species from 35 families were documented. Males 25 (64.1%) constitute the greater percentage of the total respondents. Majority of the respondents had formal education. Eighty-one medicinal plant species from 35 families were documented. Leaves are the most utilized 25.8 followed by seed 17.7 and fruits 12.1%, respectively. Relative frequency of citation ranged from 0.5 to 0.9, whereas the FL value ranged from 0.4 to 0.85, revealing how effective the documented plant species are in the management of COVID-19 in the region. A greater amount of research into documented medicinal plants is warranted because of the high likelihood that they contain many active ingredients.
ABSTRACT
Various lineages of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have contributed to prolongation of the Coronavirus Disease 2019 (COVID-19) pandemic. Several non-synonymous mutations in SARS-CoV-2 proteins have generated multiple SARS-CoV-2 variants. In our previous report, we have shown that an evenly uneven distribution of unique protein variants of SARS-CoV-2 is geo-location or demography-specific. However, the correlation between the demographic transmutability of the SARS-CoV-2 infection and mutations in various proteins remains unknown due to hidden symmetry/asymmetry in the occurrence of mutations. This study tracked how these mutations are emerging in SARS-CoV-2 proteins in six model countries and globally. In a geo-location, considering the mutations having a frequency of detection of at least 500 in each SARS-CoV-2 protein, we studied the country-wise percentage of invariant residues. Our data revealed that since October 2020, highly frequent mutations in SARS-CoV-2 have been observed mostly in the Open Reading Frame (ORF) 7b and ORF8, worldwide. No such highly frequent mutations in any of the SARS-CoV-2 proteins were found in the UK, India, and Brazil, which does not correlate with the degree of transmissibility of the virus in India and Brazil. However, we have found a signature that SARS-CoV-2 proteins were evolving at a higher rate, and considering global data, mutations are detected in the majority of the available amino acid locations. Fractal analysis of each protein's normalized factor time series showed a periodically aperiodic emergence of dominant variants for SARS-CoV-2 protein mutations across different countries. It was noticed that certain high-frequency variants have emerged in the last couple of months, and thus the emerging SARS-CoV-2 strains are expected to contain prevalent mutations in the ORF3a, membrane, and ORF8 proteins. In contrast to other beta-coronaviruses, SARS-CoV-2 variants have rapidly emerged based on demographically dependent mutations. Characterization of the periodically aperiodic nature of the demographic spread of SARS-CoV-2 variants in various countries can contribute to the identification of the origin of SARS-CoV-2.